Sumatriptan Succinate
Product Images NDC 16590-408

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 16590-408). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Sumatriptan 25mg Label 950)

Sumatriptan Succinate 25mg tablet blister pack label showing a package of 9 tablets. The label includes the generic name sumatriptan succinate, the NDC number 16590-950-09, and manufacturer Dr. Reddys Labs Ltd. It has instructions to see the package insert and a caution to keep out of reach of children. The label is from STAT Rx USA LLC in Gainesville, GA.*

FDA Label Image

Image Description (Sumatriptan 50 mg Label 408)

Sumatriptan Succinate 50 mg tablet label by STAT Rx USA LLC, showing 9 tablets in the package. The label includes the NDC 16590-408-09 and indicates the product is generic for Sumatriptan Succinate. Manufactured by Dr. Reddy's Labs Ltd. in India. The label states 'Rx Only' and instructs to keep out of reach of children, with a note to see the package insert.*

FDA Label Image

Image Description (Sumatriptan Structure)

Chemical structure of the active ingredient sumatriptan succinate, showing its molecular arrangement with labeled atoms and functional groups.*

FDA Label Image

Fig1 (Fig1)

A line graph showing the estimated probability of a response over time in minutes from dosing. The graph compares the response rates for placebo and three different doses (25 mg, 50 mg, 100 mg) of sumatriptan succinate, with response rates increasing over time for all doses compared to placebo.*

FDA Label Image

Fig2 (Fig2)

A line graph showing estimated probability of renal isolation over time in hours after the first dose, comparing placebo and three dosages (25 mg, 50 mg, 100 mg) of sumatriptan succinate. The graph shows increasing probabilities over 24 hours, with higher doses showing higher probabilities than placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.